324 related articles for article (PubMed ID: 22515365)
1. Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects.
Yang R; Shi J; Byeon IJ; Ahn J; Sheehan JH; Meiler J; Gronenborn AM; Aiken C
Retrovirology; 2012 Apr; 9():30. PubMed ID: 22515365
[TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary studies with mutated HIV-1 capsid proteins reveal structural mechanisms of lattice stabilization.
Gres AT; Kirby KA; McFadden WM; Du H; Liu D; Xu C; Bryer AJ; Perilla JR; Shi J; Aiken C; Fu X; Zhang P; Francis AC; Melikyan GB; Sarafianos SG
Nat Commun; 2023 Sep; 14(1):5614. PubMed ID: 37699872
[TBL] [Abstract][Full Text] [Related]
3. Characterization of HIV-1 uncoating in human microglial cell lines.
Ingram Z; Taylor M; Okland G; Martin R; Hulme AE
Virol J; 2020 Mar; 17(1):31. PubMed ID: 32143686
[TBL] [Abstract][Full Text] [Related]
4. Identification of capsid mutations that alter the rate of HIV-1 uncoating in infected cells.
Hulme AE; Kelley Z; Okocha EA; Hope TJ
J Virol; 2015 Jan; 89(1):643-51. PubMed ID: 25339776
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the mechanical properties of wild type and hyperstable mutants of the HIV-1 capsid.
Ramalho R; Rankovic S; Zhou J; Aiken C; Rousso I
Retrovirology; 2016 Mar; 13():17. PubMed ID: 26979152
[TBL] [Abstract][Full Text] [Related]
6. The NTD-CTD intersubunit interface plays a critical role in assembly and stabilization of the HIV-1 capsid.
Yufenyuy EL; Aiken C
Retrovirology; 2013 Mar; 10():29. PubMed ID: 23497318
[TBL] [Abstract][Full Text] [Related]
7. Compensatory substitutions in the HIV-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor.
Shi J; Zhou J; Halambage UD; Shah VB; Burse MJ; Wu H; Blair WS; Butler SL; Aiken C
J Virol; 2015 Jan; 89(1):208-19. PubMed ID: 25320302
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 capsid stability enables inositol phosphate-independent infection of target cells and promotes integration into genes.
Sowd GA; Shi J; Fulmer A; Aiken C
PLoS Pathog; 2023 Jun; 19(6):e1011423. PubMed ID: 37267431
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
Shi J; Zhou J; Shah VB; Aiken C; Whitby K
J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
[TBL] [Abstract][Full Text] [Related]
10. A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing.
Siddiqui MA; Saito A; Halambage UD; Ferhadian D; Fischer DK; Francis AC; Melikyan GB; Ambrose Z; Aiken C; Yamashita M
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167922
[TBL] [Abstract][Full Text] [Related]
11. CA Mutation N57A Has Distinct Strain-Specific HIV-1 Capsid Uncoating and Infectivity Phenotypes.
Fischer DK; Saito A; Kline C; Cohen R; Watkins SC; Yamashita M; Ambrose Z
J Virol; 2019 May; 93(9):. PubMed ID: 30814280
[TBL] [Abstract][Full Text] [Related]
12. Capsid Lattice Destabilization Leads to Premature Loss of the Viral Genome and Integrase Enzyme during HIV-1 Infection.
Eschbach JE; Elliott JL; Li W; Zadrozny KK; Davis K; Mohammed SJ; Lawson DQ; Pornillos O; Engelman AN; Kutluay SB
J Virol; 2020 Dec; 95(2):. PubMed ID: 33115869
[TBL] [Abstract][Full Text] [Related]
13. Second-site compensatory mutations of HIV-1 capsid mutations.
Noviello CM; López CS; Kukull B; McNett H; Still A; Eccles J; Sloan R; Barklis E
J Virol; 2011 May; 85(10):4730-8. PubMed ID: 21367891
[TBL] [Abstract][Full Text] [Related]
14. Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
Hulme AE; Kelley Z; Foley D; Hope TJ
J Virol; 2015 May; 89(10):5350-61. PubMed ID: 25741002
[TBL] [Abstract][Full Text] [Related]
15. PF74 Reinforces the HIV-1 Capsid To Impair Reverse Transcription-Induced Uncoating.
Rankovic S; Ramalho R; Aiken C; Rousso I
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089694
[TBL] [Abstract][Full Text] [Related]
16. Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid.
Sultana T; Mamede JI; Saito A; Ode H; Nohata K; Cohen R; Nakayama EE; Iwatani Y; Yamashita M; Hope TJ; Shioda T
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511380
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.
Zhou J; Price AJ; Halambage UD; James LC; Aiken C
J Virol; 2015 Sep; 89(17):9068-79. PubMed ID: 26109731
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
J Virol; 2017 May; 91(9):. PubMed ID: 28202766
[TBL] [Abstract][Full Text] [Related]
19. TRIM5α Restriction of HIV-1-N74D Viruses in Lymphocytes Is Caused by a Loss of Cyclophilin A Protection.
Selyutina A; Simons LM; Kirby KA; Bulnes-Ramos A; Hu P; Sarafianos SG; Hultquist JF; Diaz-Griffero F
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215956
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation.
Novikova M; Adams LJ; Fontana J; Gres AT; Balasubramaniam M; Winkler DC; Kudchodkar SB; Soheilian F; Sarafianos SG; Steven AC; Freed EO
mBio; 2018 Oct; 9(5):. PubMed ID: 30327442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
